Israeli-German study uncovers new path to understanding cancer

An Israeli-German study has identified a new mechanism through which the loss of the p53 protein, a crucial cancer suppressor, can damage cellular DNA, potentially shedding new light on tumor development. The research, led by scientists from the Hebrew University of Jerusalem and the German Cancer Research Center, found that when p53 is lost or defective, cells produce excessive amounts of RNA, consuming building blocks needed for DNA replication. This shortage leads to DNA damage and chromosome instability, which can contribute to tumor formation.

• The study observed this mechanism in cells from patients with Li-Fraumeni syndrome and other human cell types.
• Analysis of thousands of tumors showed a correlation between damaged p53 and high RNA levels.
• Restoring DNA building blocks or reducing RNA production alleviated replication stress and DNA damage.

The findings, published in "Molecular Cell," suggest that this imbalance actively contributes to DNA damage and could inform future cancer treatments by targeting excessive RNA production, though no therapy has emerged yet.